“It’s not a certainty, but the plan — and I feel pretty confident — should make it such that by June, everybody could have been immunized in the U.S.,” Moncef Slaoui, PhD, the head of Operation Warp Speed, told the station.
Dr. Slaoui also predicted that Pfizer and Moderna will be the first drugmakers to submit their vaccine candidate to the FDA for emergency use authorization, saying he thinks they will seek the approval in November or December. He also said 20 million to 40 million doses will be stockpiled and ready to distribute to priority citizens if a COVID-19 vaccine is authorized before the end of the year.
More articles on pharmacy:
Trump’s $200 Medicare drug card plan may violate election law, HHS says
Widespread vaccine distrust is uniquely American, study finds
Health policy experts urge US to release all COVID-19 vaccine clinical trial protocols
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
